Gabbard Leads House Bill to Hold Drug Companies Accountable Over Opioid Epidemic
Congresswoman Tulsi Gabbard (D-HI)late last week led co-sponsors Congressman Ro Khanna (D-CA) and Congresswoman Pramila Jayapal (D-WA) in introducing new legislation to hold drug companies accountable for profiting from America’s opioid epidemic. The Opioid Crisis Accountability Act of 2018 would prohibit and penalize drug companies for false marketing and distribution of opioids, create criminal liability for top company executives, and require drug companies to reimburse the cost for the negative economic impact of their products; the Centers for Disease Control and Prevention estimates at more than $78 billion each year. “The time for holding these drug companies and leaders accountable is long overdue. These companies rake in billions of dollars in profit every year on the backs of the American people, and not one of them has been prosecuted or held accountable. ... We cannot allow perpetrators of this epidemic to continue ruining lives in this country. We must hold those responsible accountable for the damage, heartache, and suffering they’ve caused,” said Gabbard. Senator Bernie Sanders (I-VT) introduced the Senate companion bill in April of this year. More here.